Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma

Molecular Carcinogenesis

Volumn 50, Issue 7, 2011, Pages 506-515

  Wang, Jin ^a,b   Che, Ya Ling ^a,b   Li, Gang ^b   Liu, Bin ^b   Shen, Tai Min ^a,b   Wang, Hui ^a,b   Linghu, Hua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Crk; CrkL; Epithelial ovarian carcinoma; Signal adaptor

Indexed keywords

CRK LIKE PROTEIN; DOCKING PROTEIN; ONCOPROTEIN; RAC1 PROTEIN;

ADVANCED CANCER; ARTICLE; BINDING AFFINITY; CANCER STAGING; CANCER TISSUE; CELL GROWTH; CELL INVASION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CYTOSKELETON; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-CRK;

RUMEX;

EID: 79958191504     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20745     Document Type: Article

References (33)

1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet 2002; 360: 1131-1135.
2. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572.
3. Tanaka S, Morishita T, Hashimoto Y, et al. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci 1994; 91: 3443-3447.
4. Hasegawa H, Kiyokawa E, Tanaka S, et al. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol 1996; 16: 1770-1776.
5. Gotoh T, Hattori S, Nakamura S, et al. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol 1995; 15: 6746-6753.
6. Kiyokawa E, Hashimoto Y, Kobayashi S, Sugimura H, Kurata T, Matsuda M. Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev 1998; 12: 3331-3336.
7. Feller SM, Knudsen B, Hanafusa H. Cellular proteins binding to the first Src homology 3 (SH3) domain of the proto-oncogene product c-Crk indicate Crk-specific signaling pathways. Oncogene 1995; 10: 1465-1473.
8. Bogenrieder T, Herlyn M. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 2003; 22: 6524-6536.
9. Feller SM. Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001; 20: 6348-6371.
10. Mayer BJ, Hamaguchi M, Hanafusa H. A novel viral oncogene with structure similarity to phospholipase C. Nature 1988; 332: 272-275.
11. Fioretos T, Heisterkamp N, Groffen J, Benjes S, Morris C. CRK proto-oncogene maps to human chromosome band 17p13. Oncogene 1993; 8: 2853-2855.
12. ten Hoeve J, Morris C, Heisterkamp N, Groffen J. Isolation and chromosomal localization of CrkL, a human crk-like gene. Oncogene 1993; 8: 2469-2474.
13. Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J Biol Chem 1995; 270: 2893-2896.
14. Salgia R, Uemura N, Okuda K, et al. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem 1995; 270: 29145-29150.
15. Reddien PW, Horvitz HR. CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans Nat Cell Biol 2000; 2: 131-136.
16. Mayer BJ, Baltimore D. Signalling through SH2 and SH3 domains. Trends Cell Biol 1993; 3: 8-13.
17. Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573-580.
18. Kiyokawa E, Mochizuki N, Kurata T, Mastuda M. Role of Crk oncogene product in physiologic signaling. Crit Rev Oncog 1997; 8: 329-342.
19. Feller SM, Knudsen B, Hanafusa H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J 1994; 13: 2341-2351.
20. Knudsen BS, Feller SM, Hanafusa H. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J Biol Chem 1994; 269: 32781-32787.
21. ten Hoeve J, Kaartinen V, Fioretos T, et al. Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res 1994; 54: 2563-2567.
22. Wang B, Mysliwiec T, Feller SM, Knudsen B, Hanafusa H, Kruh GD. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk. Oncogene 1996; 13: 1379-1385.
23. Matsuda M, Ota S, Tanimura R, et al. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins. J Biol Chem 1996; 271: 14468-14472.
24. Nishihara H, Tanaka S, Tsuda M, et al. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett 2002; 180: 55-61.
25. Miller CT, Chen G, Gharib TG, et al. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 2003; 22: 7950-7957.
26. Takino T, Nakada M, Miyamori H, Yamashita J, Yamada KM, Sato H. CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res 2003; 63: 2335-2337.
27. Wang L, Tabu K, Kimura T, et al. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4. Biochem Biophys Res Commun 2007; 362: 976-981.
28. Watanabe T, Tsuda M, Tanaka S, et al. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation. Mol Cancer Res 2009; 7: 1582-1592.
29. Hernández-Boluda JC, Cervantes F. Prognostic factors in chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009; 22: 343-353.
30. Fathers KE, Rodrigues S, Zuo D, et al. CrkII transgene induces atypical mammary gland development and tumorigenesis. Am J Pathol 2010; 176: 446-460.
31. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156: 263-264.
32. Linghu H, Tsuda M, Makino Y, et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 2006; 25: 3547-3556.
33. Guris DL, Fantes J, Tara D, Druker BJ, Imamoto A. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 2001; 27: 293-298.